Meta-analyses identify differentially expressed micrornas in Parkinson's disease

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• MicroRNA (miRNA) dysregulation is linked to Parkinson's disease (PD), but study results are inconsistent.
• Identifying consistently expressed miRNAs is crucial for understanding PD pathogenesis and developing diagnostic tools.

Purpose of the Study:

• To identify microRNAs (miRNAs) with consistent differential expression across all published Parkinson's disease (PD) studies.
• To analyze miRNA expression in brain, blood, and cerebrospinal fluid (CSF) samples from PD patients.

Main Methods:

• Systematic literature search of miRNA expression studies in PD.
• Meta-analysis of eligible publications, stratifying data by specimen type (brain, blood, CSF).
• Analysis of miRNA expression using effect-size and p-value based methods across studies with three or more data sets.

Main Results:

• 160 meta-analyses were performed on 47 datasets, identifying 13 significantly differentially expressed miRNAs in brain (3) and blood (10).
• Top brain miRNAs include hsa-miR-132-3p, hsa-miR-497-5p, and hsa-miR-133b; top blood miRNAs include hsa-miR-221-3p, hsa-miR-214-3p, and hsa-miR-29c-3p.
• No significant miRNA signals were found in CSF. Genome-wide association study data revealed significant associations for target genes of brain miRNAs in nine loci.

Conclusions:

• Several miRNAs exhibit significant differential expression in Parkinson's disease (PD).
• Brain miRNAs may play a role in PD pathogenesis and progression.
• Blood miRNAs show potential as biomarkers for PD diagnosis, progression, or prediction.